HiTT is an international market access consultancy based in Barcelona, Spain. We work across the public and private sectors, helping companies, research centres, and institutions develop and implement innovative healthcare solutions. Our team has over 30 years of combined experience when it comes to helping companies uncover and realise opportunities in healthcare. As your partner, we’ll work to help you navigate the pathways into the market, offering strategic advice and objective analysis that brings together perspectives from research, business, and healthcare.
We're on a mission to foster innovative projects that contribute to the sustainability of global healthcare ecosystems.
Our vision is to encourage collaborations between public and private stakeholders, helping them deliver a higher standard of healthcare.
Involvement, Commitment and Professionalism.
We focus our efforts and dedication to support companies, start-ups and institutions in the following areas of work
Expert consulting to support business strategic decission-making and investments in the healthcare sector.
MARKET ACCESS STRATEGIES
Trusted independent advisors with a payer’s perspective.
Striving to create innovative solutions for healthcare challenges.
NEWS & EVENTS
Add a subtitle in Customizer, "Latest news section"
In the wake of recent vaccination efforts, the Spanish Government had some hopeful projections: Assuming there will be no unforeseen events, the target of vaccinating 70% of the adult population during the summer would appear to be possible – at least in terms of the number of available doses.
The global innovation landscape is rapidly evolving, and across the world, decision makers continue to struggle with the uptake of novel interventions and policies.
Artificial Intelligence helps Hospital Clínic to reduce by 50% the mortality of patients with COVID-19.
The media and social networks echoed yesterday excellent news from the Hospital Clínic of Barcelona, announcing the preliminary results of their newly implemented Artificial Intelligence (AI) based software to treat COVID-19 patients
The immune system is amazingly complex, precise and synchronised to deliver effective responses against most health insults. Likewise, medical challenges need to be faced with a multidisciplinary, coordinated and target-specific approach.
At the intersection of two current topics; the COVID-19 pandemic and the global outcry regarding repeat incidences of racial discrimination and violence in the United States, lies the recent finding that the novel SARS-CoV-2 virus has hit African American and Latino communities harder than others.
In 2016, AQuAS (Catalan Agency for Health Quality and Evaluation), defined indicators used to evaluate the clinical and healthcare quality as a measurement instrument used to evaluate or measure specific aspects of the quality of care.
Before 2020 there was Good consensus that the new epidemic was obesity. Increasing prevalence, increasing incidence, limited available first line effective treatments, clear social gradient
The R&D response to the SARS-CoV-2 outbreak has been massive, promoted by unprecedented funding to support innovative solutions to fight the COVID-19 pandemic.